Imricor Medical Systems voluntary suspension request

Imricor Medical Systems, Inc. (ASX: $IMR) has requested a voluntary suspension from trading of its ordinary shares on the Australian Securities Exchange (ASX) under Listing Rule 17.2. The suspension is sought pending the release of an announcement regarding an update on a proposed capital raising.

Company's voluntary suspension details

The voluntary suspension is necessary to assist the Company in managing its continuous disclosure obligations as it expects to make a material announcement to the market in relation to a proposed capital raising. The Company has requested that the voluntary suspension remains in place until the commencement of normal trading on Monday, 5 February 2024. The Company has stated that it is not aware of any reason why the voluntary suspension should not be granted or of any further information necessary to inform the market about the voluntary suspension.

Summary of Imricor Medical Systems' voluntary suspension

Imricor Medical Systems, Inc. (ASX: $IMR) has requested a voluntary suspension from trading on the ASX to facilitate the release of an upcoming material announcement related to a proposed capital raising. The Company aims to manage its continuous disclosure obligations and has provided details in accordance with Listing Rule 17.2. The voluntary suspension is expected to be lifted upon the commencement of normal trading on Monday, 5 February 2024. The Company has expressed confidence in the necessity of the suspension and its compliance with the relevant regulations.